UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021562
Receipt number R000024863
Scientific Title Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trial
Date of disclosure of the study information 2016/03/22
Last modified on 2021/09/25 11:37:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trial

Acronym

The efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia

Scientific Title

Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trial

Scientific Title:Acronym

The efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia

Region

Japan


Condition

Condition

Dementia patients with BPSD

Classification by specialty

Neurology Geriatrics Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate exploratively the efficacy and safety of Sansoninto on behavioral and psychological symptoms of Dementia in a single-armed, open-label study.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes in neuropsychiatric inventory (NPI) score before and 4 weeks after sansonintotreatment

Key secondary outcomes

Changes in neuropsychiatric inventory (NPI) subscale before and 4 weeks after Sansoninto treatment


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

sansoninto for 4weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Diagnosed to be dementia
2) Within normal limit of serum potassium.
3) HDS-R under 20
4) Agreement to sign an informed consent.

Key exclusion criteria

1) Patient who has an allergy to Sansoninto medicine.
2) Patients considered inappropriate by the study investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keiko Ogawa

Organization

Kanazawa University

Division name

Department of Kampo Medicine

Zip code


Address

13-1,Takara-machi, Kanazawa

TEL

076-265-2918

Email

okeiko@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazumi Hirata

Organization

Kanazawa University Hospital

Division name

Department of Kampo Medicine

Zip code


Address

13-1, Takara-machi, Kanazawa

TEL

076-265-2918

Homepage URL


Email

tomato.j2364832@gmail.com


Sponsor or person

Institute

Kanazawa University

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学附属病院、映寿会みらい病院、田中町温泉病院


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 02 Month 28 Day

Date of IRB

2016 Year 02 Month 28 Day

Anticipated trial start date

2016 Year 03 Month 25 Day

Last follow-up date

2016 Year 09 Month 30 Day

Date of closure to data entry

2016 Year 10 Month 31 Day

Date trial data considered complete

2016 Year 10 Month 31 Day

Date analysis concluded

2016 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 03 Month 22 Day

Last modified on

2021 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024863


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name